🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Osimertinib as adjuvant therapy in EGFR-mutated NSCLC - approved on the same day our oncology pharmacy resident presented a journal club on the ADAURA trial!

Has been standard practice for some time, but nice to now have randomized, phase 3 data showing OS benefit (modest) for 2nd line FOLFOX in advanced biliary tract cancer: thelancet.com/journals/lanon…

Excited to share our paper in HOPARX’s JHOP! jhoponline.com/jhop-issue-arc… #Oncopharm #TwitteRx

Another new GI approval based on the KEYNOTE-811 trial - first-line treatment option incorporating pembrolizumab in HER2+ gastric cancer

Current and Future Management of HER2-Positive #MetastaticBreastCancer ASCO Publications One of best reviews about this topic by @prat_aleix Timely for #ASCO21 OncoAlert Paolo Tarantino ascopubs.org/doi/abs/10.120…

FDA Approves Ivosidenib for Patients with IDH1+ Cholangiocarcinoma. Good to have this as an option , even if it isn't as effective as we hoped it would be: cancernetwork.com/view/fda-appro… via CancerNetwork®

Outstanding new science at #ESMO21 💥CLD 18.2 CAR-T cells effective in GI cancers 💥 ORR 61% in 3L+ #gastriccancer #ESMO21 ESMO - Eur. Oncology OncoAlert

Happy World Pharmacists Day! Thankful for the path and people who helped me reach this career goal and for the people who continue working by my side each day 💊 💉

Wondering about the efficacy of everolimus + exemestane after CDK4/6 inhibitors in HR+ mBC? Check out our recently published paper! GT Budd Halle Moore, MD Jame Abraham, MD, FACP Megan Kruse @Montero_MD #oncopharm #bcsm #TwitteRx 👇 clinical-breast-cancer.com/article/S1526-…

Excited to officially be a Board Certified Oncology Pharmacist! Feeling thankful. BCOP ✅ 🎉

Came across this by surprise! Happy to have been a part of this QI project focusing on the importance of reviewing discharge medications and helping with accessibility to medications. Cory Chevalier, MD, FACP, FAAHPM Bassam Estfan jpsmjournal.com/article/S0885-…

Everything you need to know about infliximab in 3 slides - great talk on therapies used in steroid refractory irAEs by Sowmya Takkellapati, PharmD at #irAE23

defining steroid refractory irAE: evaluate FAST to switch to second line Cleveland Clinic IRAE management conference. Pauline Funchain Sowmya Takkellapati, PharmD

☑️Survey says… Seems like embedded pharmacists could be low hanging fruit for cancer centers who want to streamline immunotherapy and irAE care 🤔 #irAE23 Sowmya Takkellapati, PharmD Austin Kurkowski, PharmD Hanjie Mo, PharmD, BCOP 💊

Such a great team to work with!⭐️